One of the core raw materials of such tests are antigens capable of capturing the patient’s antibodies of interest.
DIARECT now offers SARS-CoV-2 antigens newly developed in the baculovirus/insect cell expression system outperforming reference antigens in different serological assays:
- SARS-CoV-2 Nucleocapsid (N) Protein (Cat. No. 46000/46001)
- SARS-CoV-2 Spike (S) Glycoprotein RBD (Cat. No. 46100/46101)
More information is available by clicking on the image on the right-hand side or feel free to contact us referring to this at info-dia(at)bbisolutions.com.
Your DIARECT team